Table 4.
Primary and secondary outcomes
Variable | N | Result |
---|---|---|
Hemostatic effectiveness at 24 hours | ||
Excellent | 21 | 3 (14.3%) |
Good | 21 | 7 (33.3%) |
Poor | 21 | 11 (52.4%) |
In‐hospital mortality | 21 | 8 (38.1%) |
Bleeding‐related | 21 | 8 (38.1%) |
Time to in‐hospital mortality, days | 8 | 1.5 (0‐10) |
Patients with>=1 ischemic complication | 21 | 4 (19.0%) |
Stroke | 21 | 2 (9.5%) |
Pulmonary embolism | 21 | 1 (4.8%) |
Deep venous thrombosis | 21 | 1 (4.8%) |
Bowel ischemia | 21 | 1 (4.8%) |
Liver ischemia | 21 | 1 (4.8%) |
ICU length of stay, days | 16 | 2 (1.5‐6.5) |
Hospital length of stay, days | 21 | 9 (2.5‐11) |
Data presented as median (interquartile range) or number (percent).